Remedor Biomed Ltd | Nof HaGalil is a pioneering company that is revolutionizing complex wound treatment through their patented technology. Their primary focus is on combating diabetic foot ulcers and complex skin wound conditions. Remedor Biomed aims to make a significant impact on people's lives and society as a whole, going beyond simply treating wounds.

With a highly dedicated team and extensive clinical research, Remedor Biomed is a clinical-stage biopharmaceutical company that is passionate about transforming patients' lives. They prioritize bringing safe and efficient therapies to the ever-changing wound care market. Their mission is to introduce an innovative and high-quality topical drug technology that improves complex wound healing, ultimately improving patients' health and quality of life.

They have developed an impressive range of products, with their flagship product being WOUNDAGEL™. This advanced product has shown faster healing and a greater incidence of ulcer closure in clinical trials and will soon be the only approved pharmaceutical for the treatment of diabetic neuropathic ulcers. With Remedor Biomed's groundbreaking technology and commitment to improving wound care, they are leading the way in providing better solutions for wound healing